Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Orexigen Therapeutics Inc (NASDAQ:OREX)

2.76
Delayed Data
As of Aug 27
 0.00 / 0.00%
Today’s Change
2.62
Today|||52-Week Range
9.37
-54.46%
Year-to-Date

Today’s Trading

Previous close2.76
Today’s openn.a.
Day’s range-- - --
Volume1,800
Average volume (3 months)2,342,880
Market cap$346.1M
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)+60.00%
Earnings growth (this year)-111.87%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+1,519.63%
P/E ratioNM
Price/Sales12.91
Price/Book15.25

Competitors

 Today’s
change
Today’s
% change
PRQRProQR Therapeutics N...0.000.00%
CNCEConcert Pharmaceutic...-0.02-0.13%
IDRAIdera Pharmaceutical...-0.02-0.69%
NHTCNatural Health Trend...+0.33+1.23%
Data as of 9:41am ET, 08/28/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$55.5M
Annual profit (last year)-$37.5M
Net profit margin-67.59%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael A. Narachi
CFO, Treasurer &
Chief Business Officer
Joseph P. Hagan
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers